NAS:ALLK (USA) Also trade in: Germany

Allakos Inc

$ 33.69 -2.28 (-6.33%)
Volume: 402,379 Avg Vol (1m): 298,512
Market Cap $: 1.46 Bil Enterprise Value $: 1.29 Bil
P/E (TTM): 0.00 P/B: 8.58
Earnings Power Value 0
Net Current Asset Value 3.57
Tangible Book 3.94
Projected FCF 0
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8.4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt range over the past 10 years
Min: 2.69, Med: 10000, Max: 10000
Current: 10000
2.69
10000
Interest Coverage No Debt
N/A
Altman Z-Score 66.58
DISTRESS
GREY
SAFE

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
ROE % -50.11
ROE range over the past 10 years
Min: -69.54, Med: -69.54, Max: -50.11
Current: -50.11
-69.54
-50.11
ROA % -37.39
ROA range over the past 10 years
Min: -120.63, Med: -46.54, Max: -31.29
Current: -37.39
-120.63
-31.29
ROC (Joel Greenblatt) % -989.40
ROC (Joel Greenblatt) range over the past 10 years
Min: -5720.82, Med: -5123.12, Max: -983.99
Current: -989.4
-5720.82
-983.99

» ALLK's 30-Y Financials

Financials (Next Earnings Date: 2019-08-29)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ALLK

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare
Traded in other countries 37Z.Germany
Address 75 Shoreway Road, Suite A, San Carlos, CA, USA, 94070

Ratios

Current vs industry vs history
PB Ratio 8.58
PB Ratio range over the past 10 years
Min: 0, Med: 0, Max: 23.66
Current: 8.58
0
23.66
EV-to-EBIT -22.26
EV-to-EBIT range over the past 10 years
Min: -126.47, Med: 0, Max: 0
Current: -22.26
-126.47
0
EV-to-EBITDA -22.50
EV-to-EBITDA range over the past 10 years
Min: -127.55, Med: 0, Max: 0
Current: -22.5
-127.55
0
Current Ratio 20.49
Current Ratio range over the past 10 years
Min: 5.35, Med: 22.62, Max: 34.55
Current: 20.49
5.35
34.55
Quick Ratio 20.49
Quick Ratio range over the past 10 years
Min: 5.35, Med: 22.62, Max: 34.55
Current: 20.49
5.35
34.55

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 8.58
Price-to-Tangible-Book range over the past 10 years
Min: 8.54, Med: 10.28, Max: 11.96
Current: 8.58
8.54
11.96
Earnings Yield (Joel Greenblatt) % -4.56
Earnings Yield (Greenblatt) range over the past 10 years
Min: -4.59, Med: 0, Max: 0
Current: -4.56
-4.59
0

More Statistics

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 0
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N